<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T17:57:43Z</responseDate>
  <request identifier="oai:figshare.com:article/33921656" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33921656</identifier>
        <datestamp>2026-09-18T07:00:02Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_15</setSpec>
        <setSpec>category_16</setSpec>
        <setSpec>category_45</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_122</setSpec>
        <setSpec>portal_87</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Association of mRNA SARS-CoV-2 vaccination with fatigue and functional recovery in patients with post-acute sequelae of COVID-19 (PASC)</dc:title>
          <dc:creator>Philipp Pries (25070711)</dc:creator>
          <dc:creator>Jan Fuge (532257)</dc:creator>
          <dc:creator>Michele Scharbau (25070714)</dc:creator>
          <dc:creator>Lennart Boblitz (25070717)</dc:creator>
          <dc:creator>Andrea Sauer (12539477)</dc:creator>
          <dc:creator>Nora Drick (8134809)</dc:creator>
          <dc:creator>Benjamin-Alexander Bollmann (25070720)</dc:creator>
          <dc:creator>Jannik Ruwisch (23077013)</dc:creator>
          <dc:creator>Marius M. Hoeper (9315867)</dc:creator>
          <dc:creator>Isabell Pink (9161943)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Neuroscience</dc:subject>
          <dc:subject>Physiology</dc:subject>
          <dc:subject>Sociology</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Mental Health</dc:subject>
          <dc:subject>Exercise capacity</dc:subject>
          <dc:subject>fatigue</dc:subject>
          <dc:subject>PASC</dc:subject>
          <dc:subject>SARS-CoV-2</dc:subject>
          <dc:subject>vaccination</dc:subject>
          <dc:description>&lt;p&gt;Patients with post-acute sequelae of SARS-CoV-2 (PASC) fear SARS-CoV-2 vaccine-linked symptom aggravation. Data on objective functional outcomes are limited.&lt;/p&gt; &lt;p&gt;We performed a retrospective analysis of an observational cohort at a post-COVID outpatient clinic at Hannover Medical School with standardized assessments at baseline and follow-up visit (3–6 months) in adults with confirmed SARS-CoV-2 infection and PASC. Participants were classified as vaccination (receipt of an additional SARS-CoV-2 vaccine dose between visits) or no vaccination. Primary outcomes were fatigue (Fatigue Assessment Scale) and exercise capacity (6-minute walk distance). Propensity scores matching (1:1 nearest-neighbor, ATT; caliper 0.2 SD) was performed using logistic regression. Group differences were assessed using t-tests/χ&lt;sup&gt;2&lt;/sup&gt; tests with Benjamini-Hochberg adjustment. Longitudinal changes were analyzed using linear mixed-effects models.&lt;/p&gt; &lt;p&gt;Of 193 eligible patients, 174 were analyzed, 148 remained after matching (74 per group). No significant differences between the groups were observed at baseline or follow-up after adjustment for multiple comparisons. Both groups improved over time, with no statistically significant difference in fatigue or exercise capacity.&lt;/p&gt; &lt;p&gt;Fatigue and functional performance improved over time regardless of vaccination status. We found no statistically significant association between mRNA SARS-CoV-2 vaccination and worsening symptoms or impaired recovery, although smaller effects cannot be excluded.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-18T07:00:02Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.6084/m9.figshare.33921656.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Association_of_mRNA_SARS-CoV-2_vaccination_with_fatigue_and_functional_recovery_in_patients_with_post-acute_sequelae_of_COVID-19_PASC_/33921656</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
